The American Orthopedic Society for Sports Medicine (AOSSM) will hold its annual meeting in Denver, CO, from July 10-17, 2024. This meeting will bring together sports medicine physicians, clinicians and industry professionals and feature the latest research, cutting-edge updates and discussion on the future of sports medicine. SmartTRAK will be there.
Andy Knapik, SmartTRAK Senior Analyst, Soft Tissue & Arthroscopic Technologies, will be getting the scoop on what’s new at AOSSM and will be available to meet in person at the meeting. If you or your company have important news you’d like to share, or would like to learn more about SmartTRAK, please reach out to Andy at andy.knapik@smarttrak.com.
SmartTRAK has put together highlights of recent news in sports medicine to catch you up on the “news to know” before going to AOSSM 2024. The following is just a small sampling of recent news and SmartTRAK updates from around the world compiled, reviewed and posted in real-time every day by the expert analysts
at SmartTRAK.
New Products:
Researchers look to prove that both transosseous-equivalent suture-bridge and independent double-row techniques provide comparable clinical results and retear rates for medium to massive posterosuperior RC tears. BMC Musculoskelet Disord
FNA mgmt highlighted five full launches YTD in 2024 in the high growth forefoot, minimally invasive and soft tissue markets including Grappler Knotless Anchor, Bridgeline Adaptive Tape, Mister Tendon Harvester, FJ200 Power Console and Burr System and PRECISION MIS Bunion System.
Stryker announced the launch of Citrefix, a suture anchor system for foot and ankle procedures. The new system uses Citregen, a bioresorbable material designed to mimic the chemistry and structure of native bone. SmarTRAK reported on the Citrefix 510(k) approval in Feb 2021.
Patents:
US Patent “Tap-in bone anchor with expanding ring” was issued describing devices that can wrap around elongate tissue and are capable of supporting the tissue or keeping two severed ends in close proximity to one another. 12023030
CONMED's US Patent Application "MENISCAL TRANSPLANT SYSTEM" was published relating to a meniscal transplant workstation and accompanying tools for preparing a meniscal transplant and tibial surface and mounting the transplant to a tibia. 20240207068
JNJ DePuy Synthes was issued US Patent “Methods And Devices For Repairing Meniscal Tissue” describing a suture anchor w/ an expanding ring that provides additional locking force for the device in bone. 12016545
Studies:
Patient Expenditures at Ambulatory Surgery Centers
Researchers look to categorize and trend annual out-of-pocket expenditures for arthroscopic rotator cuff repair pts relative to total healthcare utilization reimbursement and compare drivers of pt expenditures via analyses by insurance type and surgical setting. Arthroscopy
Clinical/Regulatory:
A 120-pt study has been registered for a study in France to describe the results of repairs of meniscal lesions in pediatric traumatology. clinicaltrials.gov
Riverpoint Medical received 510(k) Substantially Equivalent (SESE) clearance for its Iconix Knotless Anchor. The approval letter and device details are not yet available on the FDA website. K240213
A Comparative Prospective Study of the Arthroscopic Meniscus Repair Methods
In this study, researchers execute a prospective study evaluating different arthroscopic repair methods for youths w/ traumatic meniscus injuries. Est primary comp date May 2025; est study comp date Feb 2026. clinicaltrials.gov
Markets:
Researchers at the University of Rochester and the University of Oregon found that harnessing nanoparticles to deliver drugs precisely to a surgically repaired tendon is a promising new approach that reduces scar tissue formation and improves mechanical function. ScienceDaily
* These links can only be viewed by SmartTRAK subscribers. For more information on SmartTRAK, including how to receive a demo and subscribe, please click here.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK offers and how we can help increase proficiency, improve productivity and reduce costs for your company, just click, just click here.